Stockscreener 앱 받기
95.23
0.61%
0.58
시간 외 거래:
95.82
0.59
+0.62%
전일 마감가:
$94.65
열려 있는:
$94.685
하루 거래량:
16.33M
Relative Volume:
1.26
시가총액:
$251.88B
수익:
$64.17B
순이익/손실:
$17.12B
주가수익비율:
14.15
EPS:
6.73
순현금흐름:
$18.10B
1주 성능:
+2.23%
1개월 성능:
+10.22%
6개월 성능:
-17.43%
1년 성능:
-22.89%
1일 변동 폭
$94.69
$97.00
1주일 범위
$90.50
$97.37
52주 변동 폭
$81.04
$134.63
머크앤드컴퍼니 Stock (MRK) Company Profile
명칭
Merck Co Inc
전화
908-740-4000
주소
2000 GALLOPING HILL ROAD, KENILWORTH, NJ
MRK을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
MRK
Merck Co Inc
|
95.23 | 251.88B | 64.17B | 17.12B | 18.10B | 6.73 |
|
LLY
Lilly Eli Co
|
829.76 | 788.61B | 45.04B | 10.59B | 414.30M | 11.71 |
|
ABBV
Abbvie Inc
|
216.66 | 382.48B | 56.33B | 4.28B | 17.83B | 2.40 |
|
NVO
Novo Nordisk Adr
|
78.95 | 350.46B | 42.09B | 14.65B | 10.11B | 3.2833 |
|
JNJ
Johnson Johnson
|
167.70 | 344.63B | 88.82B | 14.07B | 18.06B | 5.79 |
머크앤드컴퍼니 Stock (MRK) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-02-18 | 다운그레이드 | Deutsche Bank | Buy → Hold |
| 2025-02-10 | 다운그레이드 | TD Cowen | Buy → Hold |
| 2025-01-08 | 다운그레이드 | Truist | Buy → Hold |
| 2024-12-20 | 다운그레이드 | BMO Capital Markets | Outperform → Market Perform |
| 2024-12-10 | 재개 | BofA Securities | Buy |
| 2024-12-04 | 업그레이드 | HSBC Securities | Hold → Buy |
| 2024-11-15 | 개시 | Wolfe Research | Peer Perform |
| 2024-11-11 | 다운그레이드 | Daiwa Securities | Buy → Neutral |
| 2024-10-17 | 개시 | Bernstein | Mkt Perform |
| 2024-03-11 | 다운그레이드 | Societe Generale | Hold → Sell |
| 2024-01-04 | 업그레이드 | TD Cowen | Market Perform → Outperform |
| 2023-11-09 | 개시 | Deutsche Bank | Buy |
| 2023-10-27 | 업그레이드 | BMO Capital Markets | Market Perform → Outperform |
| 2023-10-20 | 업그레이드 | UBS | Neutral → Buy |
| 2023-07-14 | 개시 | HSBC Securities | Hold |
| 2023-04-13 | 업그레이드 | Citigroup | Neutral → Buy |
| 2023-03-28 | 다운그레이드 | Societe Generale | Buy → Hold |
| 2023-03-13 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2023-03-06 | 개시 | Jefferies | Buy |
| 2023-02-22 | 업그레이드 | Wolfe Research | Peer Perform → Outperform |
| 2023-01-04 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2022-11-18 | 개시 | Credit Suisse | Outperform |
| 2022-10-10 | 업그레이드 | Guggenheim | Neutral → Buy |
| 2022-09-14 | 업그레이드 | Berenberg | Hold → Buy |
| 2022-07-06 | 업그레이드 | Daiwa Securities | Neutral → Buy |
| 2022-06-06 | 재개 | SVB Leerink | Outperform |
| 2022-04-06 | 재개 | Morgan Stanley | Equal-Weight |
| 2021-12-17 | 개시 | Goldman | Buy |
| 2021-12-16 | 개시 | Daiwa Securities | Neutral |
| 2021-12-13 | 다운그레이드 | UBS | Buy → Neutral |
| 2021-12-09 | 개시 | Wells Fargo | Overweight |
| 2021-12-07 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2021-11-29 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2021-11-19 | 개시 | BMO Capital Markets | Market Perform |
| 2021-11-01 | 업그레이드 | Argus | Hold → Buy |
| 2021-09-07 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2021-07-27 | 재개 | Truist | Buy |
| 2021-05-20 | 다운그레이드 | Argus | Buy → Hold |
| 2021-04-07 | 재개 | RBC Capital Mkts | Sector Perform |
| 2020-11-10 | 재개 | Bernstein | Outperform |
| 2020-09-29 | 개시 | Berenberg | Hold |
| 2020-08-03 | 업그레이드 | Goldman | Neutral → Buy |
| 2020-06-12 | 다운그레이드 | Wolfe Research | Outperform → Peer Perform |
| 2020-02-27 | 개시 | Barclays | Overweight |
| 2020-01-07 | 개시 | RBC Capital Mkts | Sector Perform |
| 2019-10-17 | 재개 | BofA/Merrill | Neutral |
| 2019-08-16 | 개시 | SVB Leerink | Outperform |
| 2019-07-03 | 개시 | Mizuho | Buy |
| 2019-05-28 | 개시 | Goldman | Neutral |
| 2019-05-13 | 업그레이드 | Atlantic Equities | Neutral → Overweight |
| 2018-10-16 | 재확인 | Citigroup | Buy |
| 2018-10-09 | 재개 | Guggenheim | Buy |
| 2018-04-23 | 업그레이드 | Goldman | Neutral → Buy |
| 2018-04-17 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2018-04-05 | 업그레이드 | Barclays | Equal Weight → Overweight |
| 2018-03-12 | 업그레이드 | Leerink Partners | Mkt Perform → Outperform |
| 2018-02-14 | 재확인 | Leerink Partners | Mkt Perform |
| 2018-02-07 | 재확인 | Morgan Stanley | Equal-Weight |
| 2018-01-16 | 업그레이드 | SunTrust | Hold → Buy |
모두보기
머크앤드컴퍼니 주식(MRK)의 최신 뉴스
Rep. Jefferson Shreve Purchases Shares of Merck & Co., Inc. (NYSE:MRK) - Defense World
2025-03-10 | Shareholders that lost money on Merck & Co., Inc.(MRK) Urged to Join Class ActionContact Levi & Korsinsky to Learn More | NYSE:MRK | Press Release - Stockhouse Publishing
ROSEN, LEADING INVESTOR COUNSEL, Encourages Merck & Co., Inc. Investors to Secure Counsel ... - Bluefield Daily Telegraph
ROSEN, LEADING INVESTOR COUNSEL, Encourages Merck & Co., Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – MRK - GlobeNewswire Inc.
Merck & Co. (MRK): One of the Most Undervalued US Stocks to Buy According to Hedge Funds - Insider Monkey
Shareholders of Merck & Co., Inc. Should Contact Levi & Korsinsky Before April 14, 2025 to Discuss Your RightsMRK - Stockhouse Publishing
MRK Purchasers Have Opportunity to Lead Merck & Co., Inc. Securities Fraud Lawsuit - PR Newswire
Merck & Co Unusual Options Activity For March 10 - Benzinga
MRK Investors Have Opportunity to Lead Merck & Co., Inc. Securities Fraud Lawsuit with the Schall Law Firm - PR Newswire
MERCK & CO., INC. (NYSE: MRK) DEADLINE ALERT: Bernstein - GlobeNewswire
MERCK & CO., INC. (NYSE: MRK) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Merck & ... - Bluefield Daily Telegraph
The Gross Law Firm Announces the Filing of a Securities Class Action on Behalf of Merck & Co., Inc.(MRK) Shareholders - PR Newswire
Is Merck & Co., Inc. (MRK) the Most Undervalued High Quality Stock to Buy According to Analysts? - Insider Monkey
Merck & Co., Inc. (MRK) Among The Best Cheap Dividend Stock To Buy Right Now - Insider Monkey
SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Merck & Co. - GlobeNewswire
Rep. Gilbert Ray Cisneros, Jr. Purchases Shares of Merck & Co., Inc. (NYSE:MRK) - Defense World
Ophthalmology - Merck
Merck & Co., Inc. Sued for Securities Law ViolationsInvestors Should Contact Levi & Korsinsky for More InformationMRK - PR Newswire
10 Most Undervalued High Quality Stocks to Buy According to Analysts - Insider Monkey
Merck & Co. Stockholder Notice: Shareholder Rights Law Firm Robbi - The National Law Review
Merck & Co. (MRK): Among the Best Undervalued Stocks to Invest In Now - Insider Monkey
The Gross Law Firm Reminds Merck & Co., Inc. Investors of - GlobeNewswire
Lawsuit filed for Investors who lost money with shares of Merck & Co., Inc. (NYSE: MRK) - openPR
Merck & Co. (MRK): An Undervalued Wide Moat Stock to Buy According to Analysts - Insider Monkey
New version of Merck's Keytruda faces possible patent battle, WSJ reports - Reuters
Moderna Eyes 2027 Launch for Cancer Vaccine Developed With Merck - Bloomberg
Merck Faces Patent Dispute Over New Keytruda Version -March 05, 2025 at 07:13 am EST - Marketscreener.com
Merck, Halozyme in patent battle over new Keytruda (MRK:NYSE) - Seeking Alpha
Is Merck & Co., Inc. (MRK) The Best Immunology Stock To Buy Now? - Insider Monkey
New version of Merck's cancer drug faces possible patent battle, WSJ reports -March 05, 2025 at 06:04 am EST - Marketscreener.com
New version of Merck's cancer drug faces patent battle, WSJ reports - NewsBreak
Exclusive | New Version of Merck’s Blockbuster Cancer Drug Threatened by Patent Battle - The Wall Street Journal
Class Action Filed Against Merck & Co., Inc. (MRK) Seeking Recovery for InvestorsContact Levi & Korsinsky - ACCESS Newswire
Bragar Eagel & Squire, P.C. Reminds Investors That Class - GlobeNewswire
ROSEN, A LEADING NATIONAL FIRM, Encourages Merck & Co., - GlobeNewswire
Lost Money on Merck & Co., Inc.(MRK)? Join Class Action Suit Seeking RecoveryContact Levi & Korsinsky - ACCESS Newswire
Merck & Co. (MRK): One of the Best Psychedelic Stocks to Buy in 2025 - Insider Monkey
Spotlight on Merck & Co: Analyzing the Surge in Options Activity - Benzinga
Bringing it all back home? Pfizer, Merck eye US manufacturing on back of Trump tariffs - BioProcess Insider
Shareholders that lost money on Merck & Co., Inc.(MRK) - GlobeNewswire
Is Merck & Co., Inc. (MRK) the Best Dividend Stock to Buy According to Billionaires? - Insider Monkey
ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Merck & Co. - Markets Insider
Trends Shaping the Global Livestock Monitoring Market 2025-2031, Featuring Case Study Analysis and Profiles of Industry GiantsMerck & Co., GEA Group, DeLaval, Nedap, Afimilk & More - GlobeNewswire
Chronic Cough Market Expected to rise, 2034 | Merck & Co, Kyorin - openPR
Investors in Merck & Co., Inc. Should Contact The Gross Law Firm Before April 14, 2025 to Discuss Your Rights – MRK - GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Merck & Co., Inc. of Class Action Lawsuit and Upcoming DeadlinesMRK - PR Newswire
The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of April 14, 2025 in Merck LawsuitMRK - PR Newswire
Merck & Co., Inc. (MRK): Among the Best Affordable Dividend Stocks to Buy According to Hedge Funds - Insider Monkey
MRK SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Merck & Co., Inc. Investors Have Opportunity to Lead Class Action Lawsuit! - Markets Insider
Merck & Co., Inc. Sued for Securities Law Violations Investors Should Contact Levi & Korsinsky for More Information MRK - ACCESS Newswire
ROSEN, A LEADING LAW FIRM, Encourages Merck & Co., Inc. Investors to Secure Counsel Before - The Bakersfield Californian
머크앤드컴퍼니 (MRK) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.09%
0.77%
자본화:
|
볼륨(24시간):